So what exactly do you think Wayne is positioning for with the appointment of an M&A adviser?
I can't see how they could be looking to acquire anything (no funds), so are we basically seeing a big 'for sale' sign? Surely you'd get a much better price after a feasibility study is completed/approved by the FDA and not before?
I'm a bit confused, there are only really two or three major potential buyers, why out-source the sale process and initiate it so early? Unless by getting an M&A advisory firm to throw around numbers several multiples higher than the current share price
helps get some FOMO happening between now and option expiry? helping ensure a cash injection from options exercising?
Hold | Held
So what exactly do you think Wayne is positioning for with the...
-
- There are more pages in this discussion • 57 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.65 |
Change
-0.060(0.38%) |
Mkt cap ! $300.8M | |||
| Open | High | Low | Value | Volume |
| $15.72 | $15.85 | $15.51 | $1.660M | 117.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 312 | $15.51 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.65 | 626 | 1 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |